GlassScriptPhysician profile
H Preston Matthews
NPI 1174546295
$5,005.20
in general payments reported to CMS, 2019-2025
26 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $115 · 2021: $863 · 2022: $1,846 · 2023: $1,025 · 2024: $792 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,952.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $715.11 | 2021-2024 | Jardiance |
| Novo Nordisk INC | $694.19 | 2021-2024 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $566.16 | 2021-2024 | Airsupra, Fasenra, Breztri |
| Abbvie INC. | $483.36 | 2021-2023 | |
| Amgen INC. | $389.00 | 2019-2024 | Otezla, Evenity, Prolia |
| Idorsia Pharmaceuticals US INC | $242.72 | 2022 | |
| Lilly USA, LLC | $206.30 | 2020-2024 | Mounjaro, Zepbound, Jardiance |
| Novartis Pharmaceuticals Corporation | $178.23 | 2022-2023 | |
| Pfizer INC. | $169.41 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $155.96 | 2022-2024 | |
| Teva Pharmaceuticals USA, INC. | $150.21 | 2022 | |
| Blue Earth Diagnostics | $123.14 | 2024 | |
| Aimmune Therapeutics, INC. | $119.26 | 2024-2025 | Zenpep |
| Abbott Laboratories | $117.06 | 2023 | Infinity |
| Nestle Healthcare Nutrition INC. | $114.36 | 2021-2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $106.07 | 2023 | Dexcom G7 Gss (161) |
| Acadia Pharmaceuticals INC | $103.77 | 2019 | |
| Horizon Therapeutics Plc | $86.30 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $76.93 | 2022 | |
| Exact Sciences Corporation | $73.66 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abiomed | $44.55 | 2024 | Impella |
| Biohaven Pharmaceutical Holding Company LTD. | $21.70 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $18.48 | 2025 | |
| Amarin Pharma, INC. | $16.80 | 2021 | |
| Glaxosmithkline, LLC. | $16.39 | 2023 | Shingrix, Arexvy |
| Viiv Healthcare Company | $16.08 | 2024 | Apretude |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw H Preston Matthews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.